content/01.abstract.md:3:dysregulated
content/01.abstract.md:3:transcriptional
content/01.abstract.md:5:GWAS
content/01.abstract.md:5:transcriptome
content/01.abstract.md:7:eQTLs
content/01.abstract.md:8:polygenic
content/01.abstract.md:10:neuropsychiatric
content/01.abstract.md:12:CRISPR
content/01.abstract.md:13:druggable
content/01.abstract.md:13:GWAS
content/01.abstract.md:13:therapeutical
content/02.introduction.md:4:phenotypes
content/02.introduction.md:5:DNase
content/02.introduction.md:6:dysregulated
content/02.introduction.md:6:GWAS
content/02.introduction.md:6:transcriptional
content/02.introduction.md:9:eQTLs
content/02.introduction.md:9:GWAS
content/02.introduction.md:11:eQTLs
content/02.introduction.md:13:GWAS
content/02.introduction.md:14:pleiotropy
content/02.introduction.md:14:polygenic
content/02.introduction.md:14:transcriptional
content/02.introduction.md:15:translational
content/02.introduction.md:18:PhenoPLIER
content/02.introduction.md:18:polygenic
content/02.introduction.md:18:transcriptional
content/02.introduction.md:19:LINCS
content/02.introduction.md:19:PhenomeXcan
content/02.introduction.md:19:transcriptional
content/02.introduction.md:22:cardiomyocytes
content/02.introduction.md:24:CRISPR
content/02.introduction.md:26:pathophysiological
content/02.introduction.md:27:neuropsychiatric
content/04.05.00.results_framework.md:1:PhenoPLIER
content/04.05.00.results_framework.md:4:PhenoPLIER
content/04.05.00.results_framework.md:5:PhenomeXcan
content/04.05.00.results_framework.md:6:datasets
content/04.05.00.results_framework.md:6:PhenoPLIER
content/04.05.00.results_framework.md:7:LV
content/04.05.00.results_framework.md:8:neutrophil
content/04.05.00.results_framework.md:8:neutrophil
content/04.05.00.results_framework.md:10:mononuclear
content/04.05.00.results_framework.md:10:PBMC
content/04.05.00.results_framework.md:11:dendritic
content/04.05.00.results_framework.md:11:mDCs
content/04.05.00.results_framework.md:11:myeloid
content/04.05.00.results_framework.md:12:PhenoPLIER
content/04.05.00.results_framework.md:15:PhenoPLIER
content/04.05.00.results_framework.md:16:Biobank
content/04.05.00.results_framework.md:16:PhenomeXcan
content/04.05.00.results_framework.md:17:dataset
content/04.05.00.results_framework.md:18:LV
content/04.05.00.results_framework.md:19:LVs
content/04.05.00.results_framework.md:19:transcriptional
content/04.05.00.results_framework.md:20:LV
content/04.05.00.results_framework.md:20:LVs
content/04.05.00.results_framework.md:20:PhenoPLIER
content/04.05.00.results_framework.md:21:LV
content/04.05.00.results_framework.md:21:LVs
content/04.05.00.results_framework.md:24:neutrophil
content/04.05.00.results_framework.md:24:neutrophil
content/04.05.00.results_framework.md:25:LV
content/04.05.00.results_framework.md:25:neutrophil
content/04.05.00.results_framework.md:25:PhenoPLIER
content/04.05.00.results_framework.md:26:LV
content/04.05.00.results_framework.md:26:LVs
content/04.05.00.results_framework.md:26:neutrophil
content/04.05.00.results_framework.md:27:GTEx
content/04.05.00.results_framework.md:27:GTEx
content/04.05.00.results_framework.md:28:transcriptional
content/04.05.01.crispr.md:1:LVs
content/04.05.01.crispr.md:3:CRISPR
content/04.05.01.crispr.md:4:CRISPR
content/04.05.01.crispr.md:4:lentiviral
content/04.05.01.crispr.md:5:ACACA
content/04.05.01.crispr.md:5:BLCAP
content/04.05.01.crispr.md:5:HILPDA
content/04.05.01.crispr.md:5:PTEN
content/04.05.01.crispr.md:5:SCAP
content/04.05.01.crispr.md:5:SRPR
content/04.05.01.crispr.md:6:LVs
content/04.05.01.crispr.md:9:phenotypes
content/04.05.01.crispr.md:11:FGSEA
content/04.05.01.crispr.md:11:LV
content/04.05.01.crispr.md:11:LVs
content/04.05.01.crispr.md:11:unadjusted
content/04.05.01.crispr.md:12:cardiometabolic
content/04.05.01.crispr.md:12:celiac
content/04.05.01.crispr.md:22:colocalization
content/04.05.01.crispr.md:22:fastENLOC
content/04.05.01.crispr.md:22:MultiXcan
content/04.05.01.crispr.md:23:SCD
content/04.05.01.crispr.md:24:ACACA
content/04.05.01.crispr.md:24:CRISPR
content/04.05.01.crispr.md:26:Behmel
content/04.05.01.crispr.md:26:Golabi
content/04.05.01.crispr.md:26:SGBS
content/04.05.01.crispr.md:28:NMR
content/04.05.01.crispr.md:29:HDL
content/04.05.01.crispr.md:29:lipoprotein
content/04.05.01.crispr.md:30:colocalization
content/04.05.01.crispr.md:30:RCP
content/04.05.01.crispr.md:35:densitometry
content/04.05.01.crispr.md:35:LVs
content/04.05.01.crispr.md:36:celiac
content/04.05.01.crispr.md:36:FGSEA
content/04.05.01.crispr.md:36:handgrip
content/04.05.01.crispr.md:36:intraocular
content/04.05.01.crispr.md:36:LVs
content/04.05.01.crispr.md:38:colocalization
content/04.05.01.crispr.md:38:LV
content/04.05.01.crispr.md:39:hypercholesterolemia
content/04.05.01.crispr.md:39:LV
content/04.05.01.crispr.md:40:ACACA
content/04.05.01.crispr.md:40:CRISPR
content/04.05.01.crispr.md:41:LV
content/04.05.01.crispr.md:42:colocalized
content/04.05.01.crispr.md:42:HMGCR
content/04.05.01.crispr.md:42:LDLR
content/04.05.01.crispr.md:42:LPL
content/04.05.01.crispr.md:42:SCD
content/04.05.01.crispr.md:43:LV
content/04.15.drug_disease_prediction.md:1:LVs
content/04.15.drug_disease_prediction.md:1:PhenoPLIER
content/04.15.drug_disease_prediction.md:3:LVs
content/04.15.drug_disease_prediction.md:4:DrugBank
content/04.15.drug_disease_prediction.md:4:LINCS
content/04.15.drug_disease_prediction.md:4:transcriptional
content/04.15.drug_disease_prediction.md:5:repurposing
content/04.15.drug_disease_prediction.md:5:transcriptome
content/04.15.drug_disease_prediction.md:5:transcriptomes
content/04.15.drug_disease_prediction.md:6:LINCS
content/04.15.drug_disease_prediction.md:8:LV
content/04.15.drug_disease_prediction.md:15:ROC
content/04.15.drug_disease_prediction.md:17:AUC
content/04.15.drug_disease_prediction.md:19:ROC
content/04.15.drug_disease_prediction.md:23:LV
content/04.15.drug_disease_prediction.md:24:pathophysiological
content/04.15.drug_disease_prediction.md:27:LVs
content/04.15.drug_disease_prediction.md:28:Nicotinic
content/04.15.drug_disease_prediction.md:30:catabolism
content/04.15.drug_disease_prediction.md:30:HDL
content/04.15.drug_disease_prediction.md:30:HDL
content/04.15.drug_disease_prediction.md:30:lipoprotein
content/04.15.drug_disease_prediction.md:31:acyltransferase
content/04.15.drug_disease_prediction.md:31:adipocyte
content/04.15.drug_disease_prediction.md:31:diacylglycerol
content/04.15.drug_disease_prediction.md:31:LDL
content/04.15.drug_disease_prediction.md:31:lipolysis
content/04.15.drug_disease_prediction.md:31:lipoproteins
content/04.15.drug_disease_prediction.md:33:LV
content/04.15.drug_disease_prediction.md:34:LV
content/04.15.drug_disease_prediction.md:34:LV
content/04.15.drug_disease_prediction.md:34:LV
content/04.15.drug_disease_prediction.md:34:LVs
content/04.15.drug_disease_prediction.md:36:colocalized
content/04.15.drug_disease_prediction.md:37:colocalized
content/04.15.drug_disease_prediction.md:37:eQTL
content/04.15.drug_disease_prediction.md:37:GWAS
content/04.15.drug_disease_prediction.md:37:hypercholesterolemia
content/04.15.drug_disease_prediction.md:37:RCP
content/04.15.drug_disease_prediction.md:37:SCD
content/04.15.drug_disease_prediction.md:38:hypercholesterolemia
content/04.15.drug_disease_prediction.md:38:lipoprotein
content/04.15.drug_disease_prediction.md:38:LPL
content/04.15.drug_disease_prediction.md:38:RCP
content/04.15.drug_disease_prediction.md:38:RCP
content/04.15.drug_disease_prediction.md:39:hypercholesterolemia
content/04.15.drug_disease_prediction.md:39:LV
content/04.15.drug_disease_prediction.md:40:RCP
content/04.15.drug_disease_prediction.md:41:HMGCR
content/04.15.drug_disease_prediction.md:41:RCP
content/04.15.drug_disease_prediction.md:42:LDLR
content/04.15.drug_disease_prediction.md:42:RCP
content/04.15.drug_disease_prediction.md:45:LVs
content/04.15.drug_disease_prediction.md:47:adipocytes
content/04.15.drug_disease_prediction.md:47:dendritic
content/04.15.drug_disease_prediction.md:47:monocytes
content/04.15.drug_disease_prediction.md:47:neutrophils
content/04.15.drug_disease_prediction.md:48:antiatherogenic
content/04.15.drug_disease_prediction.md:48:lipolysis
content/04.15.drug_disease_prediction.md:49:antidyslipidemic
content/04.15.drug_disease_prediction.md:49:nicotinic
content/04.15.drug_disease_prediction.md:52:CRISPR
content/04.15.drug_disease_prediction.md:57:interpretable
content/04.15.drug_disease_prediction.md:57:LV
content/04.15.drug_disease_prediction.md:59:granulosa
content/04.15.drug_disease_prediction.md:59:LVs
content/04.15.drug_disease_prediction.md:60:granulosa
content/04.15.drug_disease_prediction.md:61:LV
content/04.20.00.traits_clustering.md:1:LV
content/04.20.00.traits_clustering.md:1:transcriptomic
content/04.20.00.traits_clustering.md:7:dimensionality
content/04.20.00.traits_clustering.md:7:PCA
content/04.20.00.traits_clustering.md:7:UMAP
content/04.20.00.traits_clustering.md:13:LVs
content/04.20.00.traits_clustering.md:19:transcriptional
content/04.20.00.traits_clustering.md:24:interpretable
content/04.20.00.traits_clustering.md:35:MCV
content/04.20.00.traits_clustering.md:36:MCH
content/04.20.00.traits_clustering.md:37:MRV
content/04.20.00.traits_clustering.md:37:reticulocyte
content/04.20.00.traits_clustering.md:38:MSCV
content/04.20.00.traits_clustering.md:38:sphered
content/04.20.00.traits_clustering.md:39:RDW
content/04.20.00.traits_clustering.md:40:BMI
content/04.20.00.traits_clustering.md:42:HC
content/04.20.00.traits_clustering.md:43:BMR
content/04.20.00.traits_clustering.md:45:erythematosus
content/04.20.00.traits_clustering.md:45:SLE
content/04.20.00.traits_clustering.md:46:IBD
content/04.20.00.traits_clustering.md:50:reticulocyte
content/04.20.00.traits_clustering.md:50:reticulocyte
content/04.20.00.traits_clustering.md:50:reticulocytes
content/04.20.00.traits_clustering.md:51:hematocrit
content/04.20.00.traits_clustering.md:53:crit
content/04.20.00.traits_clustering.md:55:DVT
content/04.20.00.traits_clustering.md:55:intraocular
content/04.20.00.traits_clustering.md:56:ADHD
content/04.20.00.traits_clustering.md:57:allopurinol
content/04.20.00.traits_clustering.md:57:arthrosis
content/04.20.00.traits_clustering.md:57:lisinopril
content/04.20.00.traits_clustering.md:57:menarche
content/04.20.00.traits_clustering.md:57:ramipril
content/04.20.00.traits_clustering.md:59:HDL
content/04.20.00.traits_clustering.md:59:LDL
content/04.20.00.traits_clustering.md:59:lipoprotein
content/04.20.00.traits_clustering.md:59:methylene
content/04.20.00.traits_clustering.md:60:ischaemic
content/04.20.00.traits_clustering.md:61:basophil
content/04.20.00.traits_clustering.md:61:granulocyte
content/04.20.00.traits_clustering.md:61:myeloid
content/04.20.00.traits_clustering.md:61:neutrophil
content/04.20.00.traits_clustering.md:61:neutrophil
content/04.20.00.traits_clustering.md:61:neutrophil
content/04.20.00.traits_clustering.md:66:phenotypes
content/04.20.00.traits_clustering.md:69:densitometry
content/04.20.00.traits_clustering.md:71:anthropometric
content/04.20.00.traits_clustering.md:71:spirometry
content/04.20.00.traits_clustering.md:72:celiac
content/04.20.00.traits_clustering.md:72:erythematosus
content/04.20.00.traits_clustering.md:72:hypercholesterolemia
content/04.20.00.traits_clustering.md:72:keratometry
content/04.20.00.traits_clustering.md:74:initializations
content/04.20.00.traits_clustering.md:77:dimensionalities
content/04.20.00.traits_clustering.md:83:transcriptional
content/04.20.00.traits_clustering.md:85:LVs
content/04.20.00.traits_clustering.md:85:submatrix
content/04.20.00.traits_clustering.md:86:LV
content/04.20.00.traits_clustering.md:89:heatmap
content/04.20.00.traits_clustering.md:89:Heatmap
content/04.20.00.traits_clustering.md:92:LVs
content/04.20.00.traits_clustering.md:94:LVs
content/04.20.00.traits_clustering.md:95:heatmap
content/04.20.00.traits_clustering.md:95:LVs
content/04.20.00.traits_clustering.md:96:erythropoiesis
content/04.20.00.traits_clustering.md:96:LVs
content/04.20.00.traits_clustering.md:96:reticulocytes
content/04.20.00.traits_clustering.md:97:thrombocytes
content/04.20.00.traits_clustering.md:98:keratometry
content/04.20.00.traits_clustering.md:100:keratometry
content/04.20.00.traits_clustering.md:104:LVs
content/04.20.00.traits_clustering.md:106:PhenomeXcan
content/04.20.00.traits_clustering.md:108:fibroblasts
content/04.20.00.traits_clustering.md:108:myeloma
content/04.20.00.traits_clustering.md:108:organoids
content/04.20.00.traits_clustering.md:110:LVs
content/04.20.00.traits_clustering.md:110:PhenomeXcan
content/04.20.00.traits_clustering.md:110:pterygia
content/04.20.00.traits_clustering.md:113:Jurkat
content/04.20.00.traits_clustering.md:113:preeclampsia
content/04.20.00.traits_clustering.md:115:adipocytes
content/04.20.00.traits_clustering.md:115:cardiomyocytes
content/04.20.00.traits_clustering.md:115:fibroblasts
content/04.20.00.traits_clustering.md:115:keratometry
content/04.20.00.traits_clustering.md:115:mesenchymal
content/04.20.00.traits_clustering.md:115:osteoblasts
content/04.20.00.traits_clustering.md:115:stellate
content/04.20.00.traits_clustering.md:117:chronotype
content/04.20.00.traits_clustering.md:121:ADHD
content/04.20.00.traits_clustering.md:121:neurodevelopmental
content/04.20.00.traits_clustering.md:121:neuropsychiatric
content/04.20.00.traits_clustering.md:124:transcriptional
content/04.20.00.traits_clustering.md:127:microglia
content/04.20.00.traits_clustering.md:127:monocytes
content/04.20.00.traits_clustering.md:128:atherogenesis
content/04.20.00.traits_clustering.md:129:glioma
content/04.20.00.traits_clustering.md:129:microglia
content/04.20.00.traits_clustering.md:130:LDL
content/04.20.00.traits_clustering.md:131:Biobank
content/04.20.00.traits_clustering.md:133:ADHD
content/04.20.00.traits_clustering.md:133:astrocytes
content/04.20.00.traits_clustering.md:133:glioma
content/04.20.00.traits_clustering.md:133:microglia
content/04.20.00.traits_clustering.md:133:organoids
content/04.20.00.traits_clustering.md:142:LVs
content/04.20.00.traits_clustering.md:142:transcriptional
content/05.discussion.md:3:phenotypes
content/05.discussion.md:6:interpretable
content/05.discussion.md:7:transcriptional
content/05.discussion.md:10:phenotypes
content/05.discussion.md:14:cardiomyocytes
content/05.discussion.md:14:fibroblasts
content/05.discussion.md:14:keratometry
content/05.discussion.md:14:osteoblasts
content/05.discussion.md:15:datasets
content/05.discussion.md:15:phenotypes
content/05.discussion.md:20:datasets
content/05.discussion.md:21:interpretability
content/05.discussion.md:22:LVs
content/05.discussion.md:22:transcriptional
content/05.discussion.md:23:dataset
content/05.discussion.md:25:GWAS
content/05.discussion.md:25:LD
content/05.discussion.md:26:eQTLs
content/05.discussion.md:26:GWAS
content/05.discussion.md:26:LD
content/05.discussion.md:27:datasets
content/05.discussion.md:33:phenotypes
content/05.discussion.md:34:MultiXcan
content/05.discussion.md:42:datasets
content/05.discussion.md:42:interpretable
content/05.discussion.md:42:perturbagens
content/05.discussion.md:43:interpretability
content/05.discussion.md:45:phenotypes
content/07.00.methods.md:3:PhenomeXcan
content/07.00.methods.md:5:PhenomeXcan
content/07.00.methods.md:6:GWAS
content/07.00.methods.md:6:PhenomeXcan
content/07.00.methods.md:7:PrediXcan
content/07.00.methods.md:8:cis
content/07.00.methods.md:8:colocalization
content/07.00.methods.md:8:eQTL
content/07.00.methods.md:8:fastENLOC
content/07.00.methods.md:8:GWAS
content/07.00.methods.md:9:Genotype
content/07.00.methods.md:9:GTEx
content/07.00.methods.md:9:PrediXcan
content/07.00.methods.md:11:GWAS
content/07.00.methods.md:11:PrediXcan
content/07.00.methods.md:12:MultiXcan
content/07.00.methods.md:15:PrediXcan
content/07.00.methods.md:16:MultiXcan
content/07.00.methods.md:16:probit
content/07.00.methods.md:20:PLIER
content/07.00.methods.md:22:dataset
content/07.00.methods.md:23:PLIER
content/07.00.methods.md:24:deconvolutes
content/07.00.methods.md:24:LV
content/07.00.methods.md:24:PLIER
content/07.00.methods.md:25:dimensionality
content/07.00.methods.md:28:dataset
content/07.00.methods.md:28:MSigDB
content/07.00.methods.md:28:PLIER
content/07.00.methods.md:35:loadings
content/07.00.methods.md:37:LV
content/07.00.methods.md:40:LV
content/07.00.methods.md:43:MultiXcan
content/07.00.methods.md:43:PrediXcan
content/07.00.methods.md:47:proj
content/07.00.methods.md:49:PhenomeXcan
content/07.00.methods.md:52:CRISPR
content/07.00.methods.md:61:MultiXcan
content/07.00.methods.md:76:genotype
content/07.00.methods.md:91:anticorrelated
content/07.00.methods.md:92:LINCS
content/07.00.methods.md:92:PrediXcan
content/07.00.methods.md:92:transcriptional
content/07.00.methods.md:97:PrediXcan
content/07.00.methods.md:99:LVs
content/07.00.methods.md:99:LVs
content/07.00.methods.md:102:DOID
content/07.00.methods.md:102:DOID
content/07.00.methods.md:102:EFO
content/07.00.methods.md:102:PhenomeXcan
content/07.00.methods.md:107:MultiXcan
content/07.00.methods.md:107:preprocessing
content/07.00.methods.md:108:EFO
content/07.00.methods.md:108:GWAS
content/07.00.methods.md:108:MultiXcan
content/07.00.methods.md:108:Stouffer's
content/07.00.methods.md:109:polygenic
content/07.00.methods.md:110:LVs
content/07.00.methods.md:110:proj
content/07.00.methods.md:116:dataset
content/07.00.methods.md:126:ARI
content/07.00.methods.md:129:EAC
content/07.00.methods.md:139:dataset
content/07.00.methods.md:139:UMAP
content/07.00.methods.md:141:DBSCAN
content/07.00.methods.md:141:GMM
content/07.00.methods.md:143:GMM
content/07.00.methods.md:147:DBSCAN
content/07.00.methods.md:147:minPts
content/07.00.methods.md:148:minPts
content/07.00.methods.md:148:minPts
content/07.00.methods.md:149:DBSCAN
content/07.00.methods.md:149:minPts
content/07.00.methods.md:149:resampled
content/07.00.methods.md:155:RBF
content/07.00.methods.md:166:LV
content/07.00.methods.md:167:LV
content/07.00.methods.md:168:LVs
content/50.00.supplementary_material.md:14:CRISPR
content/50.00.supplementary_material.md:14:LVs
content/50.00.supplementary_material.md:26:FinnGen
content/50.00.supplementary_material.md:28:expiratory
content/50.00.supplementary_material.md:28:Spirometry
content/50.00.supplementary_material.md:30:levothyroxine
content/50.00.supplementary_material.md:31:Haematocrit
content/50.00.supplementary_material.md:32:lisinopril
content/50.00.supplementary_material.md:33:Haemoglobin
content/50.00.supplementary_material.md:35:FinnGen
content/50.00.supplementary_material.md:39:expiratory
content/50.00.supplementary_material.md:39:PEF
content/50.00.supplementary_material.md:39:Spirometry
content/50.00.supplementary_material.md:41:bendroflumethiazide
content/50.00.supplementary_material.md:47:metformin
content/50.00.supplementary_material.md:49:CRISPR
content/50.00.supplementary_material.md:55:coeliac
content/50.00.supplementary_material.md:55:malabsorption
content/50.00.supplementary_material.md:57:reticulocyte
content/50.00.supplementary_material.md:61:FinnGen
content/50.00.supplementary_material.md:61:pectoris
content/50.00.supplementary_material.md:64:malabsorption
content/50.00.supplementary_material.md:65:Coeliac
content/50.00.supplementary_material.md:65:FinnGen
content/50.00.supplementary_material.md:72:gtn
content/50.00.supplementary_material.md:73:singulair
content/50.00.supplementary_material.md:75:reticulocyte
content/50.00.supplementary_material.md:76:FinnGen
content/50.00.supplementary_material.md:81:CRISPR
content/50.00.supplementary_material.md:81:LVs
content/50.00.supplementary_material.md:88:Neutrophill
content/50.00.supplementary_material.md:89:Neutrophill
content/50.00.supplementary_material.md:95:sphered
content/50.00.supplementary_material.md:97:colour
content/50.00.supplementary_material.md:100:reticulocyte
content/50.00.supplementary_material.md:103:haemoglobin
content/50.00.supplementary_material.md:108:colour
content/50.00.supplementary_material.md:108:greying
content/50.00.supplementary_material.md:110:reticulocyte
content/50.00.supplementary_material.md:113:CRISPR
content/50.00.supplementary_material.md:119:densitometry
content/50.00.supplementary_material.md:120:densitometry
content/50.00.supplementary_material.md:121:densitometry
content/50.00.supplementary_material.md:123:colour
content/50.00.supplementary_material.md:123:greying
content/50.00.supplementary_material.md:126:coeliac
content/50.00.supplementary_material.md:126:malabsorption
content/50.00.supplementary_material.md:128:expiratory
content/50.00.supplementary_material.md:128:Spirometry
content/50.00.supplementary_material.md:129:densitometry
content/50.00.supplementary_material.md:130:Goldmann
content/50.00.supplementary_material.md:130:Intra
content/50.00.supplementary_material.md:130:Intraocular
content/50.00.supplementary_material.md:135:BMD
content/50.00.supplementary_material.md:135:densitometry
content/50.00.supplementary_material.md:136:densitometry
content/50.00.supplementary_material.md:136:QUI
content/50.00.supplementary_material.md:137:BMD
content/50.00.supplementary_material.md:137:densitometry
content/50.00.supplementary_material.md:140:Goldmann
content/50.00.supplementary_material.md:140:Intra
content/50.00.supplementary_material.md:140:Intraocular
content/50.00.supplementary_material.md:143:luteine
content/50.00.supplementary_material.md:145:CRISPR
content/50.00.supplementary_material.md:145:LVs
content/50.00.supplementary_material.md:157:AUC
content/50.00.supplementary_material.md:171:NMR
content/50.00.supplementary_material.md:174:HDL
content/50.00.supplementary_material.md:174:NMR
content/50.00.supplementary_material.md:177:PhenomeXcan
content/50.00.supplementary_material.md:181:Phecode
content/50.00.supplementary_material.md:196:AUC
content/50.00.supplementary_material.md:216:PhenomeXcan
content/50.00.supplementary_material.md:220:Phecode
content/50.00.supplementary_material.md:294:PhenomeXcan
content/50.00.supplementary_material.md:311:myxoedema
content/50.00.supplementary_material.md:312:thyrotoxicosis
content/50.00.supplementary_material.md:313:levothyroxine
content/50.00.supplementary_material.md:315:PhenomeXcan
content/50.00.supplementary_material.md:319:Phecode
content/50.00.supplementary_material.md:333:chemichals
content/50.00.supplementary_material.md:341:coeliac
content/50.00.supplementary_material.md:341:malabsorption
content/50.00.supplementary_material.md:342:Coeliac
content/50.00.supplementary_material.md:343:malabsorption
content/50.00.supplementary_material.md:345:Erythematosus
content/50.00.supplementary_material.md:348:thyrotoxicosis
content/50.00.supplementary_material.md:352:myxoedema
content/50.00.supplementary_material.md:353:levothyroxine
content/50.00.supplementary_material.md:356:PhenomeXcan
content/50.00.supplementary_material.md:360:Phecode
content/50.00.supplementary_material.md:364:polyarthropathies
content/50.00.supplementary_material.md:391:myxoedema
content/50.00.supplementary_material.md:392:levothyroxine
content/50.00.supplementary_material.md:393:thyrotoxicosis
content/50.00.supplementary_material.md:399:PhenomeXcan
content/50.00.supplementary_material.md:403:Phecode
content/50.00.supplementary_material.md:409:polyarthropathies
content/50.00.supplementary_material.md:410:DVT
content/50.00.supplementary_material.md:427:malabsorption
content/50.00.supplementary_material.md:428:Coeliac
content/50.00.supplementary_material.md:430:Erythematosus
content/50.00.supplementary_material.md:432:thyrotoxicosis
content/50.00.supplementary_material.md:435:coeliac
content/50.00.supplementary_material.md:435:malabsorption
content/50.00.supplementary_material.md:440:levothyroxine
content/50.00.supplementary_material.md:441:myxoedema
content/50.00.supplementary_material.md:443:PhenomeXcan
content/50.00.supplementary_material.md:447:Phecode
content/50.00.supplementary_material.md:452:Erythematous
content/50.00.supplementary_material.md:453:polyarthropathies
content/50.00.supplementary_material.md:461:osteopenia
content/50.00.supplementary_material.md:468:Hypotension
content/50.00.supplementary_material.md:489:bendroflumethiazide
content/50.00.supplementary_material.md:495:PhenomeXcan
content/50.00.supplementary_material.md:499:Phecode
content/50.00.supplementary_material.md:503:pectoris
content/50.00.supplementary_material.md:505:Cardiomegaly
content/50.00.supplementary_material.md:517:Sensorineural
content/50.00.supplementary_material.md:529:hypoxia
content/50.00.supplementary_material.md:529:microvascular
content/50.00.supplementary_material.md:545:Ischaemic
content/50.00.supplementary_material.md:551:revascularizations
content/50.00.supplementary_material.md:555:PhenomeXcan
content/50.00.supplementary_material.md:559:Phecode
content/50.00.supplementary_material.md:578:NMR
content/50.00.supplementary_material.md:579:Chronotype
content/50.00.supplementary_material.md:580:HDL
content/50.00.supplementary_material.md:580:NMR
content/50.00.supplementary_material.md:582:PhenomeXcan
content/50.00.supplementary_material.md:586:Phecode
content/50.00.supplementary_material.md:606:NMR
content/50.00.supplementary_material.md:607:HDL
content/50.00.supplementary_material.md:607:NMR
content/50.00.supplementary_material.md:609:PhenomeXcan
content/50.00.supplementary_material.md:613:Phecode
content/50.00.supplementary_material.md:615:Hypotension
content/50.00.supplementary_material.md:617:Hypotension
content/50.00.supplementary_material.md:634:NMR
content/50.00.supplementary_material.md:635:HDL
content/50.00.supplementary_material.md:635:NMR
content/50.00.supplementary_material.md:637:PhenomeXcan
content/50.00.supplementary_material.md:641:Phecode
content/50.00.supplementary_material.md:660:Alzheimers
content/50.00.supplementary_material.md:661:LDL
content/50.00.supplementary_material.md:661:NMR
content/50.00.supplementary_material.md:662:NMR
content/50.00.supplementary_material.md:664:PhenomeXcan
content/50.00.supplementary_material.md:668:Phecode
content/50.00.supplementary_material.md:687:LDL
content/50.00.supplementary_material.md:687:NMR
content/50.00.supplementary_material.md:688:NMR
content/50.00.supplementary_material.md:689:Alzheimers
content/50.00.supplementary_material.md:699:PhenomeXcan
content/50.00.supplementary_material.md:703:Phecode
content/50.00.supplementary_material.md:706:uninodular
content/50.00.supplementary_material.md:707:multinodular
content/50.00.supplementary_material.md:718:LVs
content/50.00.supplementary_material.md:719:LV
content/50.00.supplementary_material.md:719:thresholded
content/50.00.supplementary_material.md:722:fibroblasts
content/50.00.supplementary_material.md:730:PhenomeXcan
content/50.00.supplementary_material.md:734:Phecode
content/50.00.supplementary_material.md:736:Intervertebral
content/50.00.supplementary_material.md:737:Spondylosis
content/50.00.supplementary_material.md:739:myelopathy
content/50.00.supplementary_material.md:739:Spondylosis
content/50.00.supplementary_material.md:742:PSA
content/50.00.supplementary_material.md:752:LV
content/50.00.supplementary_material.md:755:LVs
content/50.00.supplementary_material.md:763:ARI
